scholarly journals PREVALENCE OF SENSORINEURAL HEARING LOSS IN TYPE 2 DIABETIC SUBJECTS AND ITS CORRELATION TO GLYCAEMIC STATUS AND DURATION OF DIABETES MELLITUS

2016 ◽  
Vol 5 (28) ◽  
pp. 1456-1460
Author(s):  
Arun Kumar S ◽  
Babu R ◽  
Sakthivel V ◽  
Shigil Mathew Varghese ◽  
Nikil Sam Varughese ◽  
...  
Author(s):  
Jeevan Jyoti ◽  
Ihsan Ali ◽  
Syed Waseem Abbas

<p class="Normal1"><strong>Background: </strong>The association of sensorineural hearing loss in diabetes mellitus patients is known since decades, yet there is no clear consensus among previous studies, with respect to the prevalence of SNHL in type 2 diabetes patients and the effect of duration and control of diabetes on hearing acuity. Hence the objectives of this study are to find the prevalence of SNHL in type 2 diabetes patients and to find the effect of duration and control of diabetes on hearing loss.</p><p class="Normal1"><strong>Methods: </strong>The present study was conducted on 100 type 2 diabetes patients and age and gender matched 100 non- diabetic controls in the age group of &lt;50 years, selected based on inclusion and exclusion criteria. After detailed history taking and clinical examination, all subjects underwent FBS, PPBS estimation and HbA1c evaluation was done for diabetic patients. All underwent pure tone audiometry, DPOAE and BERA and the findings were recorded and analyzed.</p><p class="Normal1"><strong>Results: </strong>Diabetes patients had insidious onset, gradually progressive, bilaterally symmetrical SNHL. SNHL is prevalent in 73% of type 2 diabetes patients compared to 16% of controls. It is aggravated with the increasing age and duration of diabetes. Poor control of diabetes showed increased prevalence of SNHL compared to good control of diabetes.</p><p class="Normal1"><strong>Conclusions: </strong>There is increased prevalence of SNHL in type 2 diabetes patients and it is more evident in patients with long duration of diabetes and more pronounced in patients with poor diabetic control.</p>


Author(s):  
Jyothi Anand Chavadaki ◽  
Mohammed Nadeem Afroze Malli

<p class="abstract"><strong>Background:</strong> The association of sensorineural hearing loss (SNHL) in diabetes mellitus patients is known since decades, yet there is no clear consensus among previous studies, with respect to the prevalence of SNHL in type 2 diabetes patients and the effect of duration and control of diabetes on hearing acuity. Hence the objectives of this study are to find the prevalence of SNHL in type 2 diabetes patients and to find the effect of duration and control of diabetes on hearing loss.</p><p class="abstract"><strong>Methods:</strong> The present study was conducted on 86 type 2 diabetes patients attending Navodaya Medical College Hospital, Raichur and age and gender matched 86 non- diabetic controls in the age group of 30-65 years, selected based on inclusion and exclusion criteria. After detailed history taking and clinical examination, all subjects underwent FBS, PPBS estimation and HbA1c evaluation was done for diabetic patients. All underwent pure tone audiometry and the findings were recorded and analyzed.  </p><p class="abstract"><strong>Results:</strong> Diabetes patients had insidious onset, gradually progressive, bilaterally symmetrical SNHL. SNHL is prevalent in 67.44% of type 2 diabetes patients compared to 23.26% of controls. It is aggravated with the increasing age and duration of diabetes. Poor control of diabetes showed increased prevalence of SNHL compared to good control of diabetes.</p><p align="left"><strong>Conclusions:</strong> There is increased prevalence of SNHL in type 2 diabetes patients and it is more evident in patients with long duration of diabetes and more pronounced in patients with poor diabetic control.</p>


2012 ◽  
Vol 18 (4) ◽  
pp. 549-557 ◽  
Author(s):  
Israel Lerman-Garber ◽  
Daniel Cuevas-Ramos ◽  
Samantha Valdés ◽  
Lorena Enríquez ◽  
Marlette Lobato ◽  
...  

2021 ◽  
Vol 14 (11) ◽  
pp. 1076
Author(s):  
Hye-Won Han ◽  
Jeong Yee ◽  
Yoon-Hee Park ◽  
Hye-Sun Gwak

Background: Statins have emerged as protective agents against sensorineural hearing loss (SNHL) associated with dyslipidemia, but the effects of statins on SNHL are not consistent. The purpose of this study was to investigate the association between statin use and the risk of SNHL using a hospital cohort. Methods: This nested case-control study included type 2 diabetic patients over the age of 18 years without a history of hearing loss. Of these, 1379 patients newly diagnosed with SNHL or tinnitus were classified as cases, and 5512 patients matched to the cases based on age, sex, and index year were classified as controls. Chi-squared tests were used to compare categorical variables between the two groups. Odds ratios (ORs) and adjusted odds ratios (AOR) were calculated from univariate and multivariable unconditional logistic regression analyses, respectively. Results: There was a significant difference in the prevalence of statin use between the cases and controls (53.7% vs. 61.2%, respectively; p < 0.001). The use of statins in type 2 diabetic patients significantly reduced the risk of SNHL or tinnitus by 24.8% (95% CI 14.2–34.1%, p < 0.001) after controlling for confounders. Similar results were found for the association between statin use and SNHL (AOR = 0.706; 95% CI 0.616–0.811, p < 0.001). The protective effects of statins against SNHL were consistent regardless of age and sex. Conclusion: The use of statins for type 2 diabetic patients was significantly associated with a reduced risk of SNHL, regardless of age and sex. Further studies are needed, especially large cohort studies, to evaluate the long-term protective effects of statins.


2020 ◽  
Vol 10 (2) ◽  
Author(s):  
Gazzaz ZJ ◽  
Makhdom MN ◽  
Dhafar KO ◽  
Maimini O ◽  
Farooq MU ◽  
...  

Objective: To find out the prevalence of otorhinolaryngological disorders in patients with diabetes mellitus who presented to Ear, Nose and Throat (ENT) clinic at Al-Noor specialist hospital, Makkah, Saudi Arabia. Materials & Methods: This observational retrospective study was carried out over a period of one year, from July 15, 2004 to July 20, 2005 by the collaboration of ENT Department and Health Research Center of Al-Noor Specialist Hospital, Makkah, Saudi Arabia. Patients’ information was collected such as the demography, types and durations of diabetes, types of diabetic treatments, and fi nal ENT diagnosis. Subjects’ random blood sugar and hemoglobin A1c (HbA1c) levels were collected on the fi rst visit to the ENT-Outpatient Department. Results: One hundred patients met the inclusion criteria; with mean age of 51.5 years (age range 14-86 years). Thirty-nine percent of the patients were at the age of 45-54 years old. Males (52%) slightly out-numbered the females. Majority had diabetes mellitus type 2 and 78% patients had high HbA1c levels indicating poor glycemic controls. The most common ENT disorder was rhinitis (19%), followed by sensorineural hearing loss (12%) and malignant otitis externa (8%). Conclusion: The most common ENT disorder in patients with diabetes mellitus type 2 was rhinitis, followed by sensorineural hearing loss. Majority of these patients had poor glycemic control, hence can explain the predominance of certain disorders over others.


Author(s):  
Abhijit V. Makwana ◽  
Pratik Sharma ◽  
Shifa Vyas ◽  
Rahul Nahar ◽  
Maya Singh

<p class="abstract"><strong>Background:</strong> The objective of the study was to evaluate the prevalence of sensorineural hearing loss in type 2 diabetes mellitus and to figure out a relation between age, sex, duration of diabetes and diabetic control.</p><p class="abstract"><strong>Methods:</strong> A cross-sectional study was conducted at Geetanjali Medical College and Hospital for 1.5 years. Patients were known case of diabetes mellitus type 2 without any other systemic illness included in the study. A total of 115 patients were involved in the study and the informed consent was taken. A detailed examination and history related to hearing loss and diabetes status with treatment was elicited. All basic blood investigations were performed on all the patients. All the patients were subjected to pure tone audiometry and impedance audiometry in a sound proof room.  </p><p class="abstract"><strong>Results:</strong> The total prevalence of sensorineural hearing loss in the study subjects was found to be 80% with most of them having mild degree of sensorineural deafness. Increase in age, longer duration and uncontrolled diabetes are the factors which had higher risk of developing sensorineural hearing loss in the study subjects.</p><p class="abstract"><strong>Conclusions:</strong> There is a strong association between sensorineural hearing loss and duration of diabetes mellitus-2. The threshold of hearing loss is increased mainly at the higher frequencies with diabetes.</p>


2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A363-A364
Author(s):  
Dharscika Arudkumaran ◽  
Albert Chang ◽  
Deviani Umadat ◽  
Deirdre Cocks Eschler

Abstract Background: Diabetes mellitus (DM) is a systemic metabolic disorder that possesses macro- and microangiopathic consequences. Studies have demonstrated that a relationship exists between sensorineural hearing loss (SNHL) and DM, particularly in patients of older age, longer disease duration, and uncontrolled DM. The pathophysiology of DM related hearing loss is poorly understood, however proposed mechanisms include ischemia, fibrosis, demyelination, and atrophy of the eighth cranial nerve. We however, present a case of acute, transient sensorineural hearing loss in the setting of diabetic ketoacidosis that resolved with blood glucose control. Clinical Case: A 34-year-old male with type 2 diabetes mellitus (A1c 6.5% -diagnosed 6 months prior), hypertension, hyperlipidemia, and morbid obesity presented with shortness of breath and acute hearing loss without tinnitus, after being treated for pneumonia and otitis media with a course of levofloxacin for 7 days. On presentation, patient was tachypneic and tachycardic. Physical examination was significant for mild erythema of the right tympanic membrane without bulging, fluid level, mastoid tenderness, or discharge. Laboratory values were significant for hyperglycemia with blood glucose of 628 mg/dL(n 70–99 mg/dL), A1c 15.9% (n 4.8–5.6%), bicarbonate 8 mmol/L (21–31 mmol/L), anion gap 37 mmol/L (9–16 mmol/L), beta-hydroxybutyrate 11.7 mmol/L (0.02–0.27 mmol/L). Venous gas was suggestive of metabolic acidosis, urinalysis was positive for moderate ketones and glucose &gt;500 mg/dL. The patient was diagnosed with diabetic ketoacidosis and was started on an insulin drip. An audiogram revealed profound bilateral sensorineural hearing loss. A Computerized tomography (CT) scan of the bilateral temporal bones was negative for abnormalities, and a magnetic resonance imaging (MRI) of the brain was negative for morphologic abnormalities of 7th and 8th cranial nerves. Infectious and rheumatologic etiologies were excluded with normal syphilis FTA-ABs, Lyme PCR, Rheumatoid factor, ANCA, and ANA. The patient received one dose of empiric prednisone. His hearing improved after 2 days with normalization of blood glucose to a range of 100–200 mg/dL. A repeat audiogram and auditory brainstem response showed significant improvement with normal bilateral hearing. Discussion: SNHL in DM typically presents in a gradual progression with bilateral involvement, affecting higher frequencies. In patients with DM, studies show that chronicity (greater than 10 years) is strongly associated with SNHL. Other variables include older age and HbA1c greater than 8%. This is the first case to demonstrate acute bilateral SNHL, associated with uncontrolled type 2 diabetes mellitus, which resolved after blood glucose control. In the appropriate context, clinicians should consider significant hyperglycemia as a possible etiology of acute hearing loss.


Sign in / Sign up

Export Citation Format

Share Document